In vivo upstream factors of mouse hepatotoxic mechanism with sustained hepatic glutathione depletion: Acetaminophen metabolite-erythrocyte adducts and splenic macrophage-generated reactive oxygen species
View abstract on PubMed
Summary
This summary is machine-generated.The spleen is critical for acetaminophen-induced liver damage, as splenic macrophages engulf drug-adducts, leading to oxidative stress and liver injury. Spleen removal significantly protects against this damage.
Area Of Science
- Hepatology
- Immunology
- Toxicology
Background
- Acetaminophen (APAP) overdose causes liver damage via reactive oxygen species (ROS) and ferroptosis.
- The role of splenic macrophages and erythrocyte interactions in APAP hepatotoxicity remains unclear.
Purpose Of The Study
- To investigate the upstream mechanisms of APAP-induced liver damage, focusing on splenic macrophage phagocytosis of APAP-erythrocyte adducts.
- To explore the role of the spleen in APAP hepatotoxicity in vivo.
Main Methods
- Splenectomy was performed on mice prior to APAP administration.
- Mice were treated with APAP, a redox probe (DCFH-DA), macrophage-depleting clodronate (CL), and a NOX2 inhibitor.
- Hepatic cytochrome P450 (CYP) 2E1 activity, hepatic glutathione (GSH) content, plasma alanine aminotransferase levels, and hepatic necrosis were assessed.
- APAP-erythrocyte adducts, splenic ferrous iron levels, and ROS production were measured.
Main Results
- Splenectomy significantly protected against APAP-induced liver injury, reducing ALT levels and necrosis.
- APAP treatment led to increased ROS around splenic macrophages and elevated splenic ferrous iron.
- Splenic macrophages engulfed APAP-erythrocyte adducts, contributing to GSH depletion and erythrocyte deformation.
- Co-treatment with DCFH-DA, CL, NOX2 inhibitor, and CYP inhibitor ameliorated liver damage and restored GSH levels.
Conclusions
- Splenic macrophages play a critical role in APAP hepatotoxicity by phagocytosing APAP-erythrocyte adducts.
- This process triggers ROS production in the spleen, leading to hepatic GSH depletion and liver damage.
- Targeting splenic mechanisms represents a potential therapeutic strategy for APAP overdose.

